Strategies to maximize treatment success in moderate to severe psoriasis: establishing treatment goals and tailoring of biologic therapies

被引:19
|
作者
Brezinski, Elizabeth A. [1 ]
Armstrong, April W. [2 ]
机构
[1] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA
[2] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO 80045 USA
关键词
ANTITUMOR NECROSIS FACTOR; INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; ULTRAVIOLET-B PHOTOTHERAPY; SEVERE PLAQUE PSORIASIS; DOUBLE-BLIND; NATIONAL PSORIASIS; PATIENT PREFERENCES; MEDICAL BOARD; PHASE-III; ETANERCEPT;
D O I
10.12788/j.sder.0086
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Achieving treatment success among patients with moderate to severe psoriasis is a clinically relevant and important issue facing clinicians and patients. Despite advances in systemic therapy, most patients with moderate to severe psoriasis are not satisfied with their treatment. We will discuss strategies to maximize treatment success through the establishment of treatment goals and tailoring of biologic therapy for patients with difficult-to-treat psoriasis. Specifically, we provide evidence-based highlights on the development of biologics, recommendations by psoriasis expert groups on treatment goals, approaches to achieve treatment to defined targets, and therapeutic strategies to customize biologic treatment for nonresponders. The discussion on nonresponders focuses on subpopulations of interest including patients with significant obesity antidrug antibody formation, personal preferences for medication administration, and treatment nonadherence. We also highlight circumstances where the selection of the systemic medication is driven by safety considerations. As expectation for efficacy and safety increases with continued biologic development for psoriasis, devising real-world treatment strategies to maximize treatment success is critical to improve the overall physical and psychosocial wellbeing of psoriasis patients. (C) 2014 Frontline Medical Communications
引用
收藏
页码:91 / 97
页数:7
相关论文
共 50 条
  • [1] The Status of Biologic Therapies in the Treatment of Moderate to Severe Psoriasis
    Menter, Alan
    [J]. CUTIS, 2009, 84 (04): : 14 - 24
  • [2] META-ANALYSIS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
    Hawkins, N. S.
    Huntley, A.
    Eaton, J.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A74 - A75
  • [3] Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States
    Anis, Aslam H.
    Bansback, Nick
    Sizto, Sonia
    Gupta, Shiraz R.
    Willian, Mary K.
    Feldman, Steve R.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2011, 22 (02) : 65 - 74
  • [4] COST-EFFECTIVENESS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN GERMANY
    Betts, K.
    Yan, Y.
    Sundaram, M.
    Hengst, N.
    Wolff, M.
    Bensimon, A. G.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A570 - A570
  • [5] The use of biologic therapies for the treatment of moderate-to-severe psoriasis in UK clinical practice
    Warren, R.
    Brown, B.
    Lavery, D.
    Ashcroft, D.
    Griffiths, C.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1411 - 1412
  • [6] COST-EFFECTIVENESS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN THE UNITED KINGDOM
    Betts, K. A.
    Sundaram, M.
    Mughal, F.
    Yan, S. Y.
    Signorovitch, J.
    Wang, K.
    Wu, E. Q.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A505 - A506
  • [7] Biologic Therapies for Moderate to Severe Psoriasis Are Not Interchangeable
    Puig, L.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2014, 105 (05): : 483 - 486
  • [8] Biologic treatment sequences in moderate-to-severe psoriasis
    Ting, Samantha
    Lowe, Patricia
    Smith, Annika
    Fernandez-Penas, Pablo
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024,
  • [9] EFFICIENCY OF BIOLOGIC AGENTS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
    Blasco, A. J.
    Lazaro, P.
    Ferrandiz, C.
    Garcia-Diez, A.
    Liso, J.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2009, 100 (09): : 792 - 803
  • [10] Adherence to biologic treatment in patients with moderate to severe psoriasis
    Garcia-Martin, Patricia
    Lamas-Velasco, Mar L.
    Godoy-Trapero, Almudena
    Montes-Torres, Andrea
    Perez-Plaza, Alejandra
    Garcia-Diez, Amaro
    Tello, Esteban Dauden
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB224 - AB224